| For: | Chen YY, Yen HH, Chou KC, Wu SS. Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: A retrospective analysis. World J Gastroenterol 2012; 18(5): 466-471 [PMID: 22346253 DOI: 10.3748/wjg.v18.i5.466] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i5/466.htm |
| Number | Citing Articles |
| 1 |
Cheng‐Hung Chien, Rong‐Nan Chien. Thalidomide induces complete remission of advanced hepatocellular carcinoma. Advances in Digestive Medicine 2014; 1(2) doi: 10.1016/j.aidm.2014.03.002
|
| 2 |
Natsuki Kurokawa, Taro Kishimoto, Kohei Tanaka, Jun Kondo, Nobuhiro Takahashi, Yutaka Miura. New approach to evaluating the effects of a drug on protein complexes with quantitative proteomics, using the SILAC method and bioinformatic approach. Bioscience, Biotechnology, and Biochemistry 2019; 83(11) doi: 10.1080/09168451.2019.1637244
|
| 3 |
FAN LIN, JIE CAO, ZHIMING HUANG, ZHENGHAO PEI, WEILI GU, SHAOFENG FAN, KUNPING LI, JIEFENG WENG. Effect of thalidomide on the proliferation of hepatoma cells assessed by osteopontin levels in nude mice. Experimental and Therapeutic Medicine 2013; 5(5) doi: 10.3892/etm.2013.1010
|
| 4 |
Michael J. Nutt, Yeung Sing Yee, Amanda Buyan, Neil Andrewartha, Ben Corry, George C.T. Yeoh, Scott G. Stewart. In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory properties. European Journal of Medicinal Chemistry 2021; 217 doi: 10.1016/j.ejmech.2021.113353
|
| 5 |
Qing Li, Yong Liu, Yang Yu. Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide. Medicine 2017; 96(51) doi: 10.1097/MD.0000000000009272
|
| 6 |
Tao Wang, Qiting Zhang, Ning Wang, Ziqi Liu, Bin Zhang, Yufen Zhao. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma. Current Medicinal Chemistry 2021; 28(16) doi: 10.2174/0929867327666201013162144
|